NM_001904.4:c.283C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001904.4(CTNNB1):c.283C>T(p.Arg95*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001904.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNNB1 | NM_001904.4 | c.283C>T | p.Arg95* | stop_gained | Exon 4 of 15 | ENST00000349496.11 | NP_001895.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29575536, 27915094, 27959697, 28191889, 33004838, 25326669) -
This sequence change creates a premature translational stop signal (p.Arg95*) in the CTNNB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNNB1 are known to be pathogenic (PMID: 23033978, 24614104, 25326669, 26350204, 28575650). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of intellectual disability syndrome (PMID: 25326669, 27959697). ClinVar contains an entry for this variant (Variation ID: 265443). For these reasons, this variant has been classified as Pathogenic. -
- -
CTNNB1-related disorder Pathogenic:1
The CTNNB1 c.283C>T variant is predicted to result in premature protein termination (p.Arg95*). This variant has been reported in patients with CTNNB1 related neurodevelopmental disorder (Kuechler et al. 2015. PubMed ID: 25326669; Posey et al. 2016. PubMed ID: 27959697). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in CTNNB1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
Medulloblastoma;C0206711:Pilomatrixoma;C0699790:Carcinoma of colon;C0919267:Ovarian neoplasm;C2239176:Hepatocellular carcinoma;C3554449:Severe intellectual disability-progressive spastic diplegia syndrome;C4539767:Exudative vitreoretinopathy 7 Pathogenic:1
- -
Severe intellectual disability-progressive spastic diplegia syndrome Pathogenic:1
This nonsense mutation is categorized as deleterious according to ACMG guidelines (PMID:18414213). It was found twice in our laboratory de novo: in a 3-year-old male with torsion dystonia, expressive language disorder, hypotonia, hyperextension of knees, microcephaly; also in a 3-year-old female with microcephaly, global delays, mixed tone, spasticity, joint contractures. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at